Prevenar 13((R)) New Pneumococcal Vaccine for Small Children and Infants

被引：0
|
作者：
Kearns, Anette [1 ]
机构：
[1] Wyeth Lederle Pharma GmbH, Storchengasse 1, A-1150 Vienna, Austria
来源：
PADIATRIE UND PADOLOGIE | 2010年 / 45卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [31] PNEUMOCOCCAL VACCINE FOR INFANTS AND TODDLERS
    Mitchell, T.
    SOUTH AFRICAN FAMILY PRACTICE, 2006, 48 (07) : 60 - 63
  • [32] Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
    Esposito, Susanna
    Principi, Nicola
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [33] Invasive Pneumococcal Disease and the Need for the New 13-valent Pneumococcal Vaccine
    Bolton, Michael
    Barson, William
    PEDIATRIC ANNALS, 2010, 39 (08): : 497 - 503
  • [34] Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children
    Olarte, Liset
    Barson, William J.
    Barson, Ryan M.
    Lin, Philana Ling
    Romero, Jose R.
    Tan, Tina Q.
    Givner, Laurence B.
    Bradley, John S.
    Hoffman, Jill A.
    Hulten, Kristina G.
    Mason, Edward O.
    Kaplan, Sheldon L.
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (05) : 767 - 775
  • [35] Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of pneumococcal meningitis in children
    Chapoutot, A. G.
    Dessein, R.
    Guilluy, O.
    Lagree, M.
    Wallet, F.
    Varon, E.
    Martinot, A.
    Dubos, F.
    EPIDEMIOLOGY AND INFECTION, 2016, 144 (03): : 607 - 611
  • [36] Safety of 13-valent pneumococcal conjugate vaccine in infants and children: Meta-analysis of 13 clinical trials in 9 countries
    Thompson, Allison
    Gurtman, Alejandra
    Patterson, Scott
    Juergens, Christine
    Laudat, France
    Emini, Emilio A.
    Gruber, William C.
    Scott, Daniel A.
    VACCINE, 2013, 31 (45) : 5289 - 5295
  • [37] Post licensure safety surveillance for Prevenar®, a 7-valent pneumococcal conjugate vaccine
    Bensouda-Grimaldi, L
    Jonville-Bera, AP
    Autret-Leca, E
    DRUG SAFETY, 2005, 28 (10) : 931 - 932
  • [38] Evaluation of immune response to the pneumococcal conjugate vaccine (Prevenar®)following transplantation in patients with myeloma
    Greenfield, H. M.
    Borrow, R.
    Warrington, R.
    Balmer, P.
    Cavet, J.
    Adams, J.
    Mutton, K.
    Yin, J. A. Liu
    BONE MARROW TRANSPLANTATION, 2007, 39 : S168 - S168
  • [39] Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers
    Yeh, Sylvia H.
    Gurtman, Alejandra
    Hurley, David C.
    Block, Stan L.
    Schwartz, Richard H.
    Patterson, Scott
    Jansen, Kathrin U.
    Love, Jack
    Gruber, William C.
    Emini, Emilio A.
    Scott, Daniel A.
    PEDIATRICS, 2010, 126 (03) : E493 - E505
  • [40] Safety experience with heptavalent pneumococcal CRM197-conjugate vaccine (Prevenar®) since vaccine introduction
    Center, Kimberly J.
    Strauss, Ann
    VACCINE, 2009, 27 (25-26) : 3281 - 3284
12345